HUM vs MBX · P/E 39, rev $129.66B vs $1.98B cap
Humana Inc (HUM) versus MBX Biosciences, Inc. Common Stock (MBX) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
MBX Biosciences, Inc. Common Stock (MBX) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
MBX does not have a complete income-statement cache yet.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. MBX currently screens at market cap $1.98B.
Not investment advice. Open the HUM and MBX stock pages for the full models.
Not investment advice.